The other role of DUSP4 in cancer is MAPK pathway inhibitor, and DUSP4 inhibition can cause the activation of ERK pathway which is involved in tumor invasiveness and drug resistance in breast and pancreatic cancer [28–30]. The gene discussed is DUSP4; the disease is familial pancreatic carcinoma.